Stem cell technology is emerging as one of the Mucopolysaccharidosis (MPS) treatment

 

Mucopolysaccharides are more popularly known are long linear, non-repetitious polysaccharide units containing at least one non-lactose sugar with an attached galactose sugar. The repeating two-dimensional sugar unit is composed of amino acid and uric acid, excluding mucopolysaccharides, where in place of the amino acid it contains galactose; the non-galactose sugar, on the other hand, is either glucose or galactose.

Mucopolysaccharides are produced in the intestines through a series of events. First, the ingested food supplies the enzymes required for glycolysis, the process that produces energy from glucose. Glucose is transported to the liver for conversion into glycogen, a material that stores fat and prevents glycolysis from being inhibited. The liver then transports the glycogen back to the small intestine where it is incorporated into long chains of glucose-free glucose and transported back into the bloodstream. These long chains eventually exit the body in the urine.

Mucopolysaccharides have also been shown to inhibit the growth of tumors and to promote cancerous treatment by inhibiting tumor metastasis and by preventing tumor immune cells from damaging the host tissue. In addition, mucopolysaccharides have been found to prevent allergic reactions in people with allergies.

The most common causes of mucopolysaccharide-induced nephritis include viral infections, chemicals, and drugs. Mucopolysaccharides may also result from certain cancers like breast cancer and lung cancer. Mucopolysaccharide is produced by the myeloid leukemia cells and may provoke symptoms like fever, weight loss, and joint and skin rashes.

Research activities upholding stem cell technology application in Mucopolysaccharidosis (MPS) Treatment research in North America, the most promising drugs are the ones that are derived from mucopolysaccharide. These drugs, which are now under phase II of clinical trials, are said to be capable of reducing the activity of Mucopolysaccharides in body cells that generate it, which can lead to preventing or slowing down the growth of certain cancer cells like leukemia and renal cell carcinoma. By using this Mucopolysaccharidosis (MPS) treatment, scientists can hope to find out how this substance affects the ability of cancerous cells to survive.